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ABSTRACT
Chronic exposure of pancreatic β-cells to saturated non-esteriﬁed fatty acids can lead to inhibition
of insulin secretion and apoptosis. Several previous studies have demonstrated that saturated fatty
acids such as PA (palmitic acid) are detrimental to β-cell function compared with unsaturated fatty
acids. In the present study, we describe the effect of the polyunsaturated AA (arachidonic acid)
on the function of the clonal pancreatic β-cell line BRIN-BD11 and demonstrate AA-dependent
attenuation of PA effects. When added to β-cell incubations at 100 μM, AA can stimulate cell
proliferation and chronic (24 h) basal insulin secretion. Microarray analysis and/or real-time PCR
indicated signiﬁcant AA-dependent up-regulation of genes involved in proliferation and fatty acid
metabolism [e.g. Angptl (angiopoietin-like protein 4), Ech1 (peroxisomal  3,5, 2,4-dienoyl-CoA
isomerase), Cox-1 (cyclo-oxygenase-1) and Cox-2, P<0.05]. Experiments using speciﬁc COX
and LOX (lipoxygenase) inhibitors demonstrated the importance of COX-1 activity for acute
(20 min) stimulation of insulin secretion, suggesting that AA metabolites may be responsible
for the insulinotropic effects. Moreover, concomitant incubation of AA with PA dose-dependently
attenuated the detrimental effects of the saturated fatty acid, so reducing apoptosis and decreasing
parameters of oxidative stress [ROS (reactive oxygen species) and NO levels] while improving the
GSH/GSSG ratio. AA decreased the protein expression of iNOS (inducible NO synthase), the p65
subunit of NF-κB (nuclear factor κB) and the p47 subunit of NADPH oxidase in PA-treated cells.
These ﬁndings indicate that AA has an important regulatory and protective β-cell action, which
may be beneﬁcial to function and survival in the ‘lipotoxic’ environment commonly associated with
Type 2 diabetes mellitus.
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serum; Gck, glucokinase; GSIS, glucose-stimulated insulin secretion; HETE, hydroxyeicosatetraenoic acid; iNOS, inducible
NO synthase; LT, leukotriene; NEFA, non-esteriﬁed fatty acid; NF-κB, nuclear factor κB; NS-398, N-(2-cyclohexyloxyl-4
nitrophenyl)methanesulfonamide; PA, palmitic acid; PI, propidium iodide; PG, prostaglandin; PLA2, phospholipase A2; Ppara,
peroxisome-proliferator-activated receptor α; Ppard, peroxisome-proliferator-activated receptor δ; ROS, reactive oxygen species;
RT–PCR (reverse transcription–PCR; SC-560, 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-(triﬂuoromethyl)-1H-pyrazole; Scd-2,
stearoyl-CoAdesaturase-2;Srebp-1c,sterol-regulatory-element-bindingprotein-1c;T2DM,Type2diabetesmellitus;TNB,2-nitro-
5-thiobenzoic acid; UCP, uncoupling protein; WST-1, water-soluble tetrazolium salt 1; WT, wild-type.
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INTRODUCTION
T2DM (Type 2 diabetes mellitus) is a metabolic disorder
characterized by elevated blood glucose concentrations.
Most cases of T2DM are also characterized by elevated
circulating fatty acid concentrations due to high
dietary lipid intake, which is associated with decreased
GSIS (glucose-stimulated insulin secretion) [1,2]. The
impairment of insulin secretion has been attributed
to insults and desensitization associated with chronic
exposure of pancreatic β-cells to elevated glucose and
NEFA (non-esteriﬁed fatty acid) levels, which can lead
to reduction in β-cell mass (glucolipotoxicity) [3,4].
It is possible that NEFAs inhibit insulin secretion by
slowing glucose uptake, metabolism and oxidation via
Randle cycle effects, where an increase in availability
of NEFA favours their oxidation leading to impaired
glucose metabolism via glycolytic inhibition [5,6]. The
exactmechanismofthecytotoxiceffectofNEFAremains
unclear, but it has been suggested that formation of
free radicals [7,8], generation of ceramides [9], activation
of endoplasmic reticulum stress and of stress-related
response genes, such as that encoding NF-κB (nuclear
factor κB) [10], could be involved in triggering apoptosis.
In vitro studies have demonstrated that saturated fatty
acids such as PA (palmitic acid) and stearic acid are
more toxic than unsaturated fatty acid such as oleic
and AA (arachidonic acid), although unsaturated fatty
acids are not entirely free of cytotoxic effects at
elevatedconcentrations[11–14].NEFAs,however,inlow
concentrations are essential for GSIS by potentiation of
GSIS and can be used as an energy substrate for β-cells
during periods of fasting and starvation.
PA is one of the most abundant saturated fatty acids
in the human diet and is the major fatty acid synthesized
de novo in the liver; in addition, its levels are elevated
in the plasma in T2DM [15,16]. Several studies have
demonstrated the detrimental effect of chronic exposure
(usually 24 h) of different pancreatic β-cell lines and
rodent islets, to PA [17]. By contrast, AA is suggested to
be an important modulator of pancreatic β-cell function,
enhancing insulin secretion and cell proliferation in vitro
[18]. The metabolism of AA by various isoforms of
COX(cyclo-oxygenase)generateslipidproductsthatcan
increase insulin secretion [16]. A recent study showed
thatconcomitantincubationofBRIN-BD11β-cellswith
inhibitors of AA mobilization altered glucose-induced
insulin secretion when compared with cells incubated in
the presence of AA [19]. BRIN-BD11 β-cells represent
a useful model for such studies, since they are stable in
cultureandhavewell-characterizedmetabolic,signalling,
insulin secretory and cell viability responses to glucose,
amino acids and numerous other modulators of β-cell
function (see [20,21] for details). Additionally, recently
published work has reported that palmitic acid and
cytokines induce effects on insulin secretion and p47phox
expression to a similar extent in both BRIN-BD11 cells
and mouse islets [22].
We have now extended these studies to investigate the
rolesofAAintheregulationofβ-cellfunctionalintegrity,
insulin secretion, gene expression, ROS (reactive oxygen




RPMI 1640 medium, penicillin/streptomycin, FBS (fetal
bovine serum) and glutamine were obtained from Gibco.
TheWST-1(water-solubletetrazoliumsalt1)cellviability
assay was obtained from Roche Diagnostics. The rat
insulin ELISA kit was obtained from Mercodia. The
Griess Reagent System for nitrite detection was obtained
from Promega. All other reagents were obtained from
Sigma–Aldrich unless otherwise stated.
Cell culture
BRIN-BD11 cells were cultured in RPMI 1640 medium
supplemented with 10% (v/v) FBS, 0.1% antibiotics
(100 units/mlpenicillinand0.1 mg/mlstreptomycin)and
2 mM glutamine and were maintained at 37◦Ci na
humidiﬁed atmosphere of 5% CO2 and 95% air using
a Forma Scientiﬁc incubator. Cells were kept between
1×105 and 1×106 cells/ml. For the experiments, cells
(1.5×105) were seeded in a 24-well plate or containing
2 ml of medium or 1.5×106 in six-well plates containing
5 ml of medium and allowed to adhere overnight before
treatmentinthepresenceorabsenceoffattyacids.Astock
solution of each fatty acid (100 mM) was prepared using
ethanol as solvent. The ﬁnal concentration of ethanol
added to the cell culture medium was always less than
0.5%, a concentration that was not toxic to the cells
(results not shown). In some experiments, PA and AA
were prepared by mixing with 90% ethanol at room
temperature(20◦C)toproducestocksolutionsof90 mM.
The fatty acid preparations were then bound to 10%
fatty-acid-free BSA (MP Biomedicals) by incubation for
1h a t 3 7◦C. The mixture was added to RPMI 1640
medium (containing 11 mM glucose) deprived of FBS.
The ﬁnal concentrations present in the cell environment
were 1% for BSA and 0.5% for ethanol. The cells were
seededintosix-wellplatesatdensitiesof105 cells/welland
incubated for 24 h in complete RPMI 1640 medium. The
medium was then removed and replaced with relevant
fatty acid–BSA complexes (in RPMI 1640 devoid of FBS)
for a further 24 h. Controls received BSA and vehicle
only.
Cell viability and relative cell number
Cell viability (or relative cell number) was assessed
using an assay based on the reduction of WST-1,
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a tetrazolium salt, to formazan by cell-dependent
mitochondrial dehydrogenase activity. An increase in
the number of viable cells results in an increase in the
overall activity of mitochondrial dehydrogenases in
the sample. Brieﬂy, BRIN-BD11 cells (2×104)w e r e
plated in a 96-well plate and allowed adhere overnight.
Cells were treated for 24 h, and at the end of incubation,
the cell proliferation assaying reagent WST-1 (10 μl)
was added to each well. The cells were incubated for
1 h in the incubator, and the formazan dye produced
was quantiﬁed by measuring its absorbance at 450 nm
using a kinetic plate reader (Spectramax Plus; Molecular
Devices). For cell viability studies using ﬂow cytometry,
fatty acids were bound to 10% fatty-acid-free BSA by
incubation at 37◦C for 1 h, and the ﬁnal concentration of
BSA was maintained at 1%. For individual experiments,
the culture medium was removed and replaced by
serum-freeRPMI1640containingappropriatefattyacid–
BSA complexes. Controls received BSA and vehicle
only.
Flow cytometry
Following incubation of cells with relevant fatty acids,
both attached and ﬂoating cells were harvested and
centrifugedat300 gfor5 min.Thepelletwasresuspended
in 200 μl of medium. PI (propidium iodide) staining
solution was prepared by mixing 20 μg/ml PI with
FACS buffer (PBS, 2% FBS and 10 mM sodium azide).
A portion (200 μl) of this PI solution was then added
to the samples and incubated on ice for 10 min. The
samples were then analysed on a Beckman Coulter Epics
XL.MCL ﬂow cytometer and analysed using EXPO32
ADC software (Applied Cytometry Systems).
Insulin secretion
Aftercellincubation,intheabsenceorpresenceofNEFA
for 24 h, the medium was removed from each well and,
in some cases, stored for later insulin measurement. The
cells were then washed with PBS, and acute insulin
secretion was determined after cell incubation for 40 min
inKRB(KrebsRingerbuffer),pH 7.4,containing1.1 mM
d-glucose, followed by subsequent stimulation for
20 min in KRB pH 7.4 containing 16.7 mM glucose plus
10 mM alanine (a robust and reproducible insulinotropic
stimulus) unless otherwise stated. The medium was then
collected, and insulin secretion was determined using a
Mercodia Ultra-sensitive Rat Insulin ELISA kit.
RT–PCR (reverse transcription–PCR)
Total RNA was isolated from cells using TRI
REAGENT (Molecular Research Center) according to
standardprotocolsprovidedbythemanufacturer.cDNA
synthesis was carried out on the total RNA using
the Superscript Preampliﬁcation System II (Invitrogen
Life Technologies). The primers used were Srebp-1c
(sterol-regulatory-element-binding protein-1c) (forward
primer, 5 -TCAGTTCCAGCATGGCTACC-3 ;r e -
verse primer, 5 -GCAGTTGATGTAGAGGCTAA-3 ),
Ppara (peroxisome-proliferator-activated receptor-α)
(forwardprimer,5 -GGTCCGATTCTTCCACTGC-3 ;
reverse primer, 5 -TCCCCTCCTGCAACTTCTC-3 ),
Ppard (peroxisome-proliferator-activated receptor-δ)
(forward primer, 5 -GCAGGCTCTAGAATTCCA-
TC-3 ; reverse primer, 5 -GCCGTGTCTGGAGTGTT-
GTG-3 ), Ampk (AMP-activated protein kinase)
(forward primer, 5 -TGCTTTGCTGTGTGGAAC-
TC-3 ; reverse primer, 5 -TGTTGTACAGGCAGCTG-
AGG-3 ), Gck (glucokinase) (forward primer, 5 -CA-
GTGGAGCGTGAAGACAAA-3 ; reverse primer, 5 -
ACCATCCGGTCATACTCCAG-3 ), and Ucp-2 (un-
coupling protein-2) (forward primer, 5 -ATTGC-
ACGAGAGGAAGGGAT-3 ;reverseprimer,5 -ATTA-
CTACGTTCAGGATCC-3 ). Expression of genes of
interest were normalized to 18S rRNA ampliﬁed from
the same samples. 18S rRNA expression levels were not
altered by any treatment reported in the present study.
Microarray
Total RNA from the cells was isolated using RNeasy kit
(Qiagen). RNA samples were prepared for microarray
analysis using the GeneChip System (Affymetrix).
Brieﬂy, cDNA synthesis was performed using the
First-Strand cDNA Synthesis Kit. The double-stranded
cDNA was then cleaned using the GeneChip Sample
Cleanup module. Synthesis of biotin-labelled cRNA was
then prepared using the GeneChip IVT Labelling kit.
Subsequently, the biotin-labelled cRNA was cleaned
using the GeneChip Sample Cleanup module and
following quantiﬁcation was fragmented at 94◦Cp r i o r
to hybridization with Rat Genome 230 2.0 Array. After
hybridization, the arrays were washed and stained on a
GeneChipFluidicsStation(Affymetrix).Thepreliminary
preprocessing and the comparative gene expression
analysis of this data was carried out using freeware
fromtheBioconductorwebsite(www.bioconductor.org).
Transcripts representing genes with a value of >1.7-fold





(Molecular Research Center) according to the manufac-
turer’s protocol. cDNA synthesis was carried out on
the total RNA using the Superscript Preampliﬁcation
SystemII(InvitrogenLifeTechnologies).Real-timePCR
TaqManassaywasusedtoquantifytherelativeexpression
levels of genes identiﬁed as differentially expressed by
microarray data. To eliminate the possibility of genomic
DNA contamination, RNA samples (1 μg) were digested
with DNase I before reverse transcription. DNase-
treated RNA samples were then used as templates for
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ﬁrst-strandcDNAsynthesis,usingSuperScriptIIreverse
transcriptase and random primers; 2 μlo fc D N Aw a s
used for real-time PCR analysis. The probes for the
target genes were labelled with the ﬂuorescent dye,
FAM on the 5 -end and a non-ﬂuorescent quencher
on the 3 -end. 18S rRNA was used as an endogenous
control for normalization of the target genes. PCR
reactionsweresetupwithTaqmanUniversalPCRMaster
Mix from Applied Biosystems. cDNA was ampliﬁed
on the 7900HT Sequence Detection System (Applied
Biosystems). Results were analysed using the relative
standard curve method of analysis/ Ct (threshold cycle)
method of analysis.
ROS detection
After incubation, cells were washed with PBS and
lysed with lysis buffer (containing 1% Triton-X100 and
40 mM EDTA). Lysates were then transferred to a 96-
well opaque plate and incubated for 30 min with 10 μM
H2DCFDA (2 ,7 ,di-hydrochloroﬂuorescein-diacetate)
(Molecular Probes). Its oxidation by ROS releases
DCF (2 ,7 -dichloroﬂuorescein), which is ﬂuorescent




Cells were seeded in an opaque 96-well plate, and after
treatment,10μMDHE(dihydroethidine)wasaddedand
incubated for 30 min in the dark and under agitation.
This probe is oxidized in the presence of superoxide,
and ethidium is released. Ethidium is a ﬂuorescent




NO production was measured indirectly by nitrite
quantiﬁcation, which is a stable NO oxidation product.
Nitrite was measured using the Griess Reagent System
(Promega) by following the manufacturer’s protocol.
Intracellular GSH (reduced glutathione)
and GSSG (oxidized glutathione)
measurement
Intracellular GSH and GSSG content was determined
using a protocol described by Rahman et al. [23]. The
assay is based on the reaction of GSH with DTNB
[5,5 -dithiobis-(2-nitrobenzoic acid)] (also known as
Ellman’s reagent), which produces the TNB (2-nitro-5-
thiobenzoic acid) chromophore, which has a maximal
absorbance at 412 nm, and GSSG–TNB adduct). The
rate of formation of TNB, measured at 412 nm, is
proportional to the concentration of GSH in the sample.
The disulﬁde product (GSSG–TNB) is then reduced
by glutathione reductase in the presence of NADPH,
recycling GSH back into the reaction.
Brieﬂy, cells were lysed in an extraction buffer (0.1%
Triton X-100 and 0.6% sulfosalicylic acid in 0.1 M
potassium phosphate buffer with 5 mM EDTA disodium
salt, pH 7.5) for 15 min under agitation and centrifuged
at 12000 g for 10 min. The supernatant was collected
and stored at −80◦C. An aliquot was kept for protein
measurement.
For GSH measurement, samples and GSH standards
were added to a 96-well plate with a reaction
mixture containing DTNB, β-NADPH and glutathione
reductase, and the absorbance was read at 412 nm using
a Spectramax Plus Plate Reader (Molecular Devices).
Results are expressed as μg/mg of protein.
ForGSSGmeasurement,samplesandGSSGstandards
wereincubatedwith2-vinylpyridineandtriethanolamine
for 1 h at room temperature and then transferred to a 96-
well plate and read at 412 nm. Results are expressed as
μg/mg of protein.
Western blot analysis
After the incubation period, cells were trypsinized and
centrifuged at 1200 g for 10 min and homogenized in
extraction buffer (100 mM Tris/HCl, pH 7.0, 10 mM
EDTA, 100 mM NaF, 10 mM sodium pyrophosphate
and 10 mM sodium orthovanadate). The samples were
sonicated and SDS (10%) was added, followed by 30 min
of incubation on ice. After that, samples were centrifuged
at 12000 g, for 40 min, at 4◦C. Aliquots of supernatants
were used for measurement of total protein content as
previouslydescribed[18].Equalamountsofproteinfrom
each sample were separated using SDS/PAGE. Western
blotting was carried out using standard protocols.
Statistical analysis
The results are presented as means+ −S.E.M. and were
analysed by one-way or two-way ANOVA with Tukey
or Bonferroni post-hoc tests respectively. The level of
signiﬁcance was set at P<0.05.
RESULTS
Effect of AA on relative cell number
Incubation of BRIN-BD11 cells with AA (up to
150 μM) for 24 h did not impair cell viability when
compared with control, as determined by WST-1
analysis or ﬂow cytometry. WST-1 is widely used to
determinemitochondrialdehydrogenaseactivity,making
the assumption that viable cells contain fully functional
mitochondria, and therefore WST-1 absorbance is
proportional to cell number. The addition of 100 μMo f
AA, however, stimulated cell proliferation, increasing the
cellpopulationby19%whencomparedwiththecontrol.
IncubationoftheBRIN-BD11cellswitharelativelyhigh
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Figure 1 Effect of AA on relative cell number
BRIN-BD11 β-cells were incubated in the absence or presence of various
concentrations of AA for 24 h (50–150 μM AA). Relative cell number was
assessed using an assay based on the reduction of WST-1, a tetrazolium salt,
to formazan by cellular mitochondrial dehydrogenase activity. An increase in
the number of viable cells results in an increase in the overall mitochondrial
dehydrogenase activity. Results are normalized to 100% and are expressed as
means+ −S.E.M., for six independent experiments. ∗P <0.05 compared with
WST-1 absorbance from control cells.
Figure 2 Effect of AA on acute (20 min) insulin secretion
BRIN-BD11 β-cells were incubated in the absence (Ctrl) or presence of 100
μM AA for 24 h. Subsequently, an acute (20 min) determination of basal-
(1.1 mM glucose; black bars) and nutrient- (16.7 mM glucose and 10 mM alanine;
white bars) stimulated insulin secretion was made. Results are expressed as
means+ −S.E.M., for six independent experiments. ∗P <0.05 compared with
basal insulin secretion from control cells.
level of 150 μM AA resulted in a decrease in cell viability
and therefore a reduction in relative cell number when
compared with cells incubated with 100 μM, but not
when compared with the vehicle control (Figure 1).
Effect of AA on acute (20 min) insulin
secretion
A signiﬁcant increase in basal- (1.1 mM glucose), but
not nutrient-, (16.7 mM glucose and 10 mM alanine)
stimulated (20 min) insulin secretion (P<0.05) was
observed following 24 h exposure to 100 μM AA, when
compared with the vehicle control (Figure 2).
Effect of AA on gene expression
RT–PCR analysis comparing Srebp-1c, Ppard, Ppara, Ins
(proinsulin), Ucp-2, Ampk and Gck mRNA expression
in BRIN-BD11 cells treated in the absence or presence of
increasing concentrations of AA for 24 h was performed.
A signiﬁcant (P<0.05) increase in the relative expression
of Ampk mRNA was observed in BRIN-BD11 cells
stimulated for 24 h with 100 μM AA, compared with
untreated control cells.
There was a signiﬁcant (P<0.01) decrease in relative
expression of Srebp-1c following 24-h exposure to 50 or
100 μM AA compared with cells cultured in control
medium, whereas the relative expression levels of Ppara
and Ppard mRNA in cells treated with 50 or 100 μMA A
was also signiﬁcantly (P<0.05) reduced compared with
control cells. However, there was no signiﬁcant change
inproinsulin,Ucp-2orGckmRNAexpressionfollowing
24-h stimulation with AA.
Microarray analysis and subsequent data analysis
(using freeware from the Bioconductor website
(www.bioconductor.org) revealed that four genes were
signiﬁcantly altered in response to chronic (24 h)
treatment of BRIN-BD11 cells with 100 μMA A
(Table 1). The down-regulation of Scd-2 (stearoyl-CoA
desaturase) and Abcg1 (ATP-binding cassette subfamily
G member 1) observed using microarray analysis was
conﬁrmed using real-time PCR (Figures 3A and 3B). The
up-regulation of Ech1 (peroxisomal  3,5, 2,4-dienoyl-
CoA isomerase) and Angptl4 (angiopoietin-like protein
4), both detected by microarray analysis, was also
conﬁrmed by using real-time PCR (Figures 3C and 3D).
Effect of COX/LOX (lipoxygenase)
inhibitors in combination with AA on
insulin secretion
In order to determine whether the effects of AA on
β-cell function were mediated by the products of AA
metabolism or by AA itself, speciﬁc COX enzyme
inhibitors and a non-selective LOX enzyme inhibitor
were added to the cell culture medium for 24 h prior
to the determination of acute nutrient stimulated insulin
secretion (Figure 4). The selectivity of various COX
inhibitors has recently been reviewed [24].
Selective inhibition of COX-1 by 100 μM acet-
aminophen decreased signiﬁcantly (P<0.05) the extent
ofnutrient-stimulatedinsulinsecretioninthepresenceof
100 μM AA. This ﬁnding suggests that the inhibition of
theCOX-1pathwayresultsinalossofAA-derivedmeta-
bolites, which contribute to d-glucose- and l-alanine-
stimulatedinsulinsecretion.Nodifferenceswerefoundin
basal insulin secretion. Inhibition of COX-1 with 10 μM
SC-560 [5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-
(triﬂuoromethyl)-1H-pyrazole] in combination with
100 μM AA, however, signiﬁcantly (P<0.05) enhanced
insulin secretion measured under non-stimulating
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Table 1 Microarray gene expression analysis following 24 h of AA treatment
List of BRIN-BD11 β-cell genes differentially regulated >1.7-fold following 24-h incubation with 100 μM AA compared with vehicle control.
Function GenBank® accession no. Gene name Fold change P value
Lipid metabolism NM_031841 Stearoyl-CoA desaturase-2 (Scd-2) −3.87 0.0018
Cholesterol transport/lipid trafﬁcking NM_053502 ATP-binding cassette transporter
subfamily G member 1 (Abcg1)
−1.7 0.0284
Angiogenesis/differentiation AA818262 Angiopoietin-like protein 4 (Angptl4) +2.72 0.0134
Fatty acid metabolism mitochondrial
and peroxisomal
NM_022594 Peroxisomal  3,5, 2,4-dienoyl CoA
isomerase (Ech1)
+1.73 0.0284
Figure 3 Effect of AA on gene expression as determined by real-time PCR.
BRIN-BD11 β-cells were cultured in the absence (Ctrl) or presence of 100 μM AA for 24 h. Expression of (A) Scd-2,( B )Abcg-1,( C )Ech1 and (D) Angptl4 was
determined by real-time PCR and normalized to 18S rRNA ampliﬁed from the same samples. Results are means+ −S.E.M. for three individual experiments where, for each
condition, they were performed in duplicate. The relative ratio for the control cells was arbitrarily set to 1. ∗P <0.05 and ∗∗P <0.01 compared with the control
cells.
Figure 4 Effect of COX/LOX inhibitors in combination with AA on insulin secretion
BRIN-BD11 β-cells were incubated in the absence (Ctrl) or presence of 100 μM AA or 100 μM AA in combination with 100 μM acetaminophen (Acet) or 100 μM
indomethacin (Indo) or 100 μM NS-398 or 10 μM SC-560 for 24 h. Subsequently, an acute (20 min) determination of basal- and nutrient- (D-glucose and L-alanine)
stimulated insulin secretion was obtained. Results are expressed as means+ −S.E.M. for six independent experiments. ∗P <0.05 and ∗∗P <0.01 compared with cells
incubated with control medium; #P <0.05 and ##P <0.01 compared with cells incubated with 100 μM AA and stimulated with 16.7 mM D-glucose and 10 mM
L-alanine.
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conditions compared with control. There was no
signiﬁcant effect on nutrient-stimulated insulin secretion
from cells incubated with SC-560 and AA.
Combinations of 100 μM indomethacin (a non-
speciﬁc COX and LOX inhibitor) with 100 μMA A
signiﬁcantly reduced basal- (P<0.01) and nutrient-




in the presence of 100 μM AA signiﬁcantly enhanced
basal- (P<0.05) and nutrient- (P<0.01) stimulated
insulin secretion when compared with control. The
increase in nutrient-stimulated insulin secretion in the
presence of NS-398 and exogenous AA was also
signiﬁcantly elevated (P<0.01) when compared with
BRIN-BD11 cells incubated with 100 μM AA alone.
Effect of PA or AA on expression levels
of COX-1 and COX-2
The incubation of BRIN-BD11 cells with PA for 24 h
did not change the expression levels of Cox-1 or Cox-2
mRNA (Figure 5). Incubation with AA (100 μM) alone
or in combination with PA, signiﬁcantly increased the
expression of both enzymes when compared with the
no-AA control. Additionally, concomitant incubation of
PA and AA (100 μM) for 24 h signiﬁcantly reduced
the expression levels of Cox-1 and Cox-2 mRNA,
compared with AA alone, in a PA-concentration-
dependent manner.
Rescue of PA-incubated cells by AA
Incubation of BRIN-BD11 cells with PA for 24 h
decreased relative cell number in a dose-dependent
manner as determined by WST-1 analysis (P<0.001;
Table 2). However, concomitant incubation with AA
protectedBRIN-BD11cellsfromthetoxiceffectofPAin
adose-dependentmannerasdeterminedeitherbyWST-1
analysis (Table 2) or by ﬂow cytometry (Figure 6A). The
two experiments described in Table 2 and Figure 6(A)
were performed using different methods of fatty acid
delivery. The fatty acids were added to the incubation
medium in ethanol only in the experiment described in
Table 2, while the fatty acids were delivered complexed
to BSA in the experiment described in Figure 6(A).
The latter revealed that the cytoprotective response
was extremely potent with an EC50 ∼2 μM (total AA
concentration) under the experimental conditions used
and that AA caused complete protection against the
cytotoxicity induced by 250 μMP A .
Effect of PA and AA on insulin secretion
measured over 24 h
PA decreased cumulative insulin secretion over a 24-h
incubation period in a dose-dependent manner (P<0.05;
Figure 5 Effect of PA or AA on expression levels of Cox-1
and Cox-2
BRIN-BD11 cells were incubated and in the absence or presence of 100 μMA A
and in the absence or presence of increasing concentrations of PA as indicated
for 24 h. After this time, the cells were harvested, and the expression levels of
Cox-1 (A) or Cox-2 (B) were determined by real-time PCR. Expression levels were
subsequently normalized to Gapdh (glyceraldehyde-3-phosphate dehydrogenase)
expression. Results are means+ −S.E.M. for three individual experiments. A
signiﬁcant improvement in cell viability (∗P <0.05 and ∗∗P <0.001) was
observed at all concentrations of AA tested.
Figure 6B). Concomitant incubation of PA and AA
(100 μM) signiﬁcantly increased insulin secretion at all
concentrations of PA used compared with incubation
with PA only (P<0.0001; Figure 6B).
Inﬂuence of PA and AA on oxidative stress
An increase in the production of total ROS
and superoxide was observed in BRIN-BD11
cells following incubation with 100 or 150 μM
PA for 24 h. Incubation with 100 μM AA alone did
not alter either the production of ROS or superoxide
when compared with control. AA, however, when added
in combination with 100 or 150 μM PA, signiﬁcantly
decreased the level of superoxide and, at 150 μMP A ,
signiﬁcantly decreased the level of ROS (Figures 7A and
7B).
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Table 2 Rescue of PA-incubated cells by AA as determined by WST-1 absorbance analysis
BRIN BD11 β-cells were incubated in the absence or presence of various concentrations of PA and/or AA at 100 μMf o r2 4 h
(50–150 μM PA). Cell viability and proliferation was assessed using an assay based on the reduction of WST-1, a tetrazolium salt, to
formazan by cellular mitochondrial dehydrogenase activity and was normalized to 100%. An increase in the number of viable cells results in
an increase in the overall activity of mitochondrial dehydrogenases in the sample. Results are expressed as normalized means+ −S.E.M. for six
independent experiments. ∗P <0.05, ∗∗P <0.01 and ∗∗∗P <0.0001 compared with cell viability from control cells (no fatty acid)
Relative mitochondrial dehydrogenase activity (%)
Treatment Control PA (μM)... 50 100 150
−100 μM AA 100.00+ −1.1 93.96+ −0.5 70.84+ −1.86∗∗∗ 58.55+ −1.03∗∗∗
+100 μM AA 119.0+ −2.75∗ 98.33+ −0.66 83.46+ −1.54∗ 67.56+ −5.36∗∗
Figure 6 Rescue of PA-incubated cells by AA determined by
ﬂow cytometry (A), and effect of PA and AA on chronic (24 h)
insulin secretion (B)
(A) BRIN-BD11 cells were incubated in the presence of 250 μM PA complexed to
BSA in the absence or increasing concentrations of AA as indicated for 24 h. After
this time, the cells were harvested and their viability assessed by ﬂow cytometry
after staining with PI. A signiﬁcant improvement in cell viability (P <0.01) was
observed at all concentrations of AA tested. (B) BRIN-BD11 β-cells were incubated
in the presence of various concentrations of PA (50–150 μM non-complexed)
in the absence or presence of 100 μM AA for 24 h. After the 24-h incubation
period, an aliquot of the medium was removed, and the concentration of
insulin was determined. The results are expressed as means+ −S.E.M., for three
separate determinations each measured in duplicate, relative to cells incubated
in the absence of fatty acid (#P <0.05) or compared with the equivalent
PA-only-treated cells (∗P <0.05).
Effect of PA and AA on nitrite production
NO was determined by quantifying nitrite, an oxidative
productofNO.Cellsincreasedtheirproductionofnitrite
when incubated with 100 or 150 μMo fP A( P<0.0001).
However, concomitant incubation of AA and PA
decreased the production of nitrite when compared with
PA-only-treated cells (P<0.001) (Figure 7C).
Effect of PA and AA on protein expression
PA increased the protein expression of subunit p65 of
NF-κB and subunit p47 of NADPH oxidase in a dose-
dependent manner. AA, when added concomitantly with
PA, decreased the expression of these proteins compared
with PA-only-treated cells.
The protein level of the enzyme responsible for
NO generation, iNOS (inducible NO synthase), was
increased following incubation in the presence of PA.
A combination of AA and PA signiﬁcantly decreased
iNOS expression compared with PA-only-treated cells
(Figure 8).
Effect of PA and AA on glutathione
metabolism
Incubation of cells in the presence of PA resulted in
a decrease in intracellular GSH in a dose-dependent
manner, while the content of GSSG was increased. AA
addition to cells, which were also treated with PA,
increased the concentration of GSH and decreased the
concentration of GSSG, contributing to an increase in
the ratio of GSH/GSSG when compared with the group
incubated with PA only (Figure 9).
DISCUSSION
The effects of NEFAs on β-cell function are complex.
Pancreatic islets exposed to high concentrations of
NEFAs for periods of 24–48 h [3] display enhanced
insulin secretion in the presence of a non-stimulatory
glucose concentration, decreased insulin synthesis,
depletion of stored insulin and an impaired response of
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Figure 7 Inﬂuence of PA and AA on oxidative stress and
nitrite production
BRIN-BD11 cells were incubated for 24 h in the presence of different concentrations
of PA and 100 μM AA. (A) ROS production was quantiﬁed using the H2DFCH probe.
Results are expressed as means+ −S.E.M., for three independent experiments. (B)
Superoxide production was measured using the DHE probe. Results are expressed
as means+ −S.E.M., for ﬁve independent experiments.#P <0.0001 compared with
the no-fatty-acid control. (C) Nitrite production was measured using the Griess
Reagent kit according to the manufacturer’s instructions. Results are expressed as
means+ −S.E.M., for n = 5 independent experiments. #P <0.0001 compared
with the no-fatty-acid control. ∗P <0.0001 compared with the respective group
without 100 μM AA.
the β-cell to stimulation by high glucose concentrations,
allofwhicharecharacteristicofthealteredβ-cellfunction
associated with T2DM. Rat and human islets exposed
to elevated levels of NEFAs for 48 h also demonstrated
increased basal insulin release (glucose concentration was
3 mM), but decreased release at an elevated (stimulatory)
glucose concentration (27 mM) [25].
TheeffectsofhighconcentrationsofNEFAonisolated
islets and clonal pancreatic insulin-secreting cells are
dependent on the structure (i.e. whether saturated or
Figure 8 Effect of PA and AA on protein expression
BRIN-BD11 cells were incubated for 24 h in the presence of different concentrations
of PA and 100 μM AA. Expression of the p65 subunit of NF-κB, p47 of NADPH
oxidase and iNOS was analysed by Western blotting after gel-based protein
separation (A). The absorbances of the bands were measured and normalized
to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) protein expression (B–D).
Results are expressed as means+ −S.E.M., for three independent experiments.
P <0.05 compared with cells incubated in the absence of fatty acid; #P <0.05
compared with the equivalent PA-only-treated cells.
unsaturated) of the fatty acid and the period of exposure
during cell culture. Acute exposure (1–3 h) of pancreatic
islets to saturated NEFA enhances insulin secretion [26]
and plays a critical role in modulating the stimulatory
effect of glucose on insulin release [27]. Acute removal
of exogenous NEFA may, however, result in excessively
high rates of glucose-stimulated insulin secretion [28].
The latter results may argue in favour of a buffering
role for NEFA, such that islet cells utilize some glucose
(in the form of a downstream metabolite, glycerol 3-
phosphate) for formation of TAG (triacylglycerol), so as
to ensure that excessively high rates of insulin secretion
do not occur. Expression of UCP-2 in β-cells is increased
by NEFAs. UCPs are located in the mitochondrial
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Figure 9 Effect of PA and AA on glutathione metabolism
BRIN-BD11 cells were incubated for 24 h in the presence of different concentrations
of PA and 100 μM AA. (A) Intracellular content of GSH was measured. (B)
Intracellular content of GSGG was measured. (C) GSH/GSSG ratio. Results are
expressed as means+ −S.E.M., for three independent experiments. *P <0.0001
compared with the no-fatty-acid control. In (A and B). #P <0.0001 compared
with the respective group without 100 μM AA.
inner membrane and act as proton channels. They
uncouple the electrochemical gradient produced by
the respiratory chain from ATP synthesis [29]. Up-
regulation of UCP-2 expression or overactivity of UCP-
2 leads to inhibition of ATP synthesis and alteration
in levels of ROS generation. NEFAs increase UCP-
2 mRNA and protein levels in several cells including
β-cells. As a result, ATP synthesis is reduced, and GSIS is
blunted. Ucp-2-knockout mice have lower fasting blood
glucose and elevated insulin levels when fed with a
high-fat diet compared with WT (wild-type) mice [30].
Exposure to PA reduced GSIS in WT islets, whereas
Ucp-2−/− islets had enhanced GSIS. While saturated NE-
FAs may induce detrimental effects on β-cell function in
part via increased UCP-2 expression, we clearly demon-
strated in the present study (microarray and PCR data)
that the polyunsaturated NEFA AA did not increase
Ucp-2 expression, therefore avoiding any UCP-2-
dependent deleterious effects associated with saturated
NEFAs. Saturated NEFAs can lead to excessive ROS
generation from mitochondrial and extramitochondrial
sourcessuchasNADPHoxidasein β-cells,accompanied
by the loss of antioxidant defence via glutathione
depletion [31–33]. Additionally, NO generation in
pancreatic β-cells may be stimulated through liga-
tion and signalling via the NEFA receptor GPR40
(G-protein-related protein 40) [34], a possible regulator
of iNOS expression [35]. NO competes with molecular
oxygen at Complex IV of the electron-transport chain,
leading to impaired oxidative phosphorylation and ATP
generation, which can induce dysregulation of cellular
Ca2+ homoeostasis resulting in endoplasmic reticulum
stress [36–38].
In contrast with the deleterious effects associated
with elevated saturated fatty acids, reports suggest
that non-esteriﬁed AA is critical for normal pancreatic
β-cell function. For example, studies in which the
release of endogenous AA was attenuated by inhibiting
PLA2 (phospholipase A2) activity, revealed a signiﬁcant
reduction in GSIS from human islets [39]. The release
of endogenous AA from the plasma membrane via
PLA2-dependent hydrolysis of phospholipids has been
identiﬁed as an important signalling event [40–42].
Exogenous addition of AA has been reported to augment
insulin secretion from pancreatic β-cells [43], which is
in agreement with results obtained for chronic (24 h)
insulin secretion in the present study (Figure 6B). We
havenowprovidedfurthermechanisticdataontheaction
of AA. The positive effects of AA described here could
result from the direct second messenger functions of
this molecule, or they could derive from metabolism of
AA to biologically active products. Metabolism of non-
esteriﬁedAAbyCOXenzymesyieldsPGs(prostagland-
ins), while LOX enzymes generate LTs (leukotrienes)
and HETEs (hydroxyeicosatetraenoic acids). Previous
experiments evaluating the functional effects of PGs
(most notably PGE2)o nt h eβ-cell have implicated PGs
in the inhibition of glucose-stimulated insulin secretion
from a hamster-derived cell line [44]. However, HETEs
and LTs produced from LOX enzyme activity augment
GSIS [45]. In the present study, we have demonstrated
thatinhibitionoftheCOX-1pathwayofAAmetabolism
resulted in an inhibition of d-glucose- and l-alanine-
stimulated insulin secretion from BRIN-BD11 cells, in
thepresenceofexogenouslyaddedAA.Thisisconsistent
with the possibility that COX-2 metabolites (which
will be preferentially generated in these conditions) are
inhibitory to nutrient-stimulated insulin secretion. In
contrast, selective inhibition of COX-2 using NS-398
(100 μM) in combination with 100 μM exogenously
added AA signiﬁcantly (P<0.05) enhanced both
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basal- and nutrient-stimulated insulin secretion com-
pared with BRIN-BD11 cells incubated with control
media (Table 1). This may indicate that COX-1
metabolites (which will be preferentially generated under
these conditions) are stimulatory to basal- and nutrient-
stimulated insulin secretion. We also demonstrated that
BRIN-BD11 cell COX-1 and COX-2 expression was
not altered when incubated with PA. In contrast, AA
signiﬁcantly increased the expression of both enzymes.
However,PAwasabletoreduceenhancedAAexpression
in a dose-dependent manner. The latter ﬁndings correlate
well with the insulinotropic effects of addition of both
AA and PA over 24 h of incubation (Figure 6B)
The ability of AA to cause down-regulation of
Scd-2 and Abcg1 and the up-regulation of Ech1 and
Angptl4geneexpression(Figure3)wouldinferadecrease
in synthesis of unsaturated fatty acids (Scd-2)a n da
decrease in cholesterol transport to HDL (high-density
lipoprotein) (Abcg1). An increase in isomerization
activity (Ech1) would favour the entry of unsaturated
fatty acids into the pathway of β-oxidation, whereas
an increase in Angptl4 signals a potential increase in
cholesterol synthesis. The expression changes identiﬁed
by microarray analysis and conﬁrmed with real-time
PCRwouldthereforepredictgreaterlevelsofunsaturated
fatty acid oxidation but a potential increase in cholesterol
synthesis and transport in the presence of AA.
The AA-mediated rescue of BRIN-BD11 cells from
PA-mediated dysfunction, as reported in the present
work, is remarkable and supports earlier data obtained
in MIN6 cells [46] This response may be mediated
by a reduction in oxidative and inﬂammatory stress as
indicated by reductions in NF-κB, iNOS and NADPH
oxidase subunit levels and a reduction in NO and ROS
levels respectively, resulting in a corresponding increase
in the GSH/GSSG ratio. The positive impact of AA with
respect to its effect on cellular oxidative stress is a novel
ﬁnding and must be considered as a key mechanism of
cell protection with respect to fatty-acid-induced β-cell
dysfunction. The molecular mechanisms could involve
AA- or PG-mediated changes in signal transduction,
subsequent gene expression and their resulting impact
on redox and inﬂammatory signalling pathways.
It is clear that further work on the mechanisms of
cytoprotection by AA (and/or downstream metabolites)
and its ability to modulate insulin secretion is required.
This may reveal novel therapeutic options for the
treatment of T2DM.
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